MRSA related topics we can do 1. Rising Incidence of MRSA in Pediatric Abscesses: A 3-Year Retrospective Analysis of 30 Cases 2. Community-Acquired MRSA Abscesses in Children: A 3-Year Retrospective Study on Trends, Management, and Prevention 3. Pediatric MRSA Abscesses: A 3-Year Retrospective Review of Incidence, Antibiotic Susceptibility, and Preventive Strategies 4. MRSA in Pediatric Skin and Soft Tissue Infections: A 3-Year Retrospective Study and Implications for Antibiotic Stewardship 5. The Changing Face of Pediatric Abscesses: Rising MRSA Prevalence and the Case for Judicious Antibiotic Use — A 3-Year Retrospective Study 6. Pediatric MRSA Abscesses on the Rise: A 3-Year Retrospective Study of 30 Cases
Searching PubMed
MRSA pediatric abscess retrospective study
Searching PubMed
community-acquired MRSA children skin soft tissue infection
Searching the Web
pediatric MRSA abscess retrospective study title examples published journals 2022 2023 2024
Here is a detailed breakdown and recommendation for each title option, followed by a clear verdict:
Title Analysis: MRSA Pediatric Abscess Retrospective Study
Criteria Used for Evaluation
- Clarity and specificity - Does it state exactly what the study does?
- Keyword optimization - Are searchable terms (MRSA, pediatric, abscess, retrospective) prominent?
- Scope accuracy - Does it match a 30-case, 3-year, single-center retrospective?
- Journal conventions - Does it follow patterns seen in Pediatr Infect Dis J, J Pediatr, Pediatrics, Pediatr Surg Int?
- Avoidance of editorial red flags - No clichés, no em dashes (some journals auto-reject these in titles), no overclaiming
Option-by-Option Review
| # | Title | Strengths | Weaknesses | Score |
|---|---|---|---|---|
| 1 | Rising Incidence... 30 Cases | Simple, states n=30, clear | "Rising Incidence" is a strong claim that requires statistical trend analysis to support; no mention of antibiotic susceptibility | 6/10 |
| 2 | Community-Acquired MRSA... Trends, Management, Prevention | Broad scope keywords; "Trends, Management, Prevention" is descriptive | Very long; "Community-Acquired" narrows scope - does your data distinguish CA-MRSA from HA-MRSA? If not, this overclaims | 6.5/10 |
| 3 | Pediatric MRSA Abscesses: Incidence, Antibiotic Susceptibility, Preventive Strategies | Clean colon structure; all 3 pillars stated explicitly; strong keyword density | "3-Year Retrospective Review" is slightly redundant after "Retrospective" | 8.5/10 |
| 4 | MRSA in Pediatric SSTIs: Retrospective Study and Antibiotic Stewardship | "Antibiotic Stewardship" is a high-value, indexed keyword; SSTI framing broadens relevance | "Implications for" is weak hedging language - implies you don't directly measure stewardship outcomes | 7.5/10 |
| 5 | The Changing Face... - A 3-Year Retrospective Study | Creative, attention-grabbing | Em dash (many journals reject this in titles); "Changing Face" is a well-worn cliché in medical literature; "The" opener is discouraged by most style guides; weakest SEO | 4/10 |
| 6 | Pediatric MRSA Abscesses on the Rise: 30 Cases | Brief and punchy | "on the Rise" is informal/sensationalist for a peer-reviewed paper; n=30 is modest and may undermine the claim | 5.5/10 |
Top Recommendation: Title #3
Pediatric MRSA Abscesses: A 3-Year Retrospective Review of Incidence, Antibiotic Susceptibility, and Preventive Strategies
Why #3 wins:
- The subtitle triplet (Incidence / Antibiotic Susceptibility / Preventive Strategies) maps directly onto the three things reviewers expect from this kind of study
- "Antibiotic Susceptibility" is a concrete, measurable outcome - it does not overclaim like "antibiotic stewardship" does (unless you directly tracked stewardship metrics)
- Strong MeSH/PubMed index alignment: "Methicillin-Resistant Staphylococcus aureus," "Pediatrics," "Abscess," "Anti-Bacterial Agents/pharmacology"
- Matches the structural conventions of titles published in Pediatr Infect Dis J and J Pediatric Infect Dis Soc (e.g., "Pediatric Orbital Cellulitis/Abscess: Microbiology and Pattern of Antibiotic Prescribing" - PMID 36940123)
- No editorial red flags
Secondary Recommendation: Title #4 (if your study includes antibiotic use analysis)
MRSA in Pediatric Skin and Soft Tissue Infections: A 3-Year Retrospective Study and Implications for Antibiotic Stewardship
Use this if your paper discusses prescribing patterns, appropriateness of empiric therapy, or makes policy recommendations - "antibiotic stewardship" is a trending MeSH term with high citation relevance. Drop "Implications for" and reframe as "Antibiotic Stewardship Considerations" to sound less hedged.
One Suggested Refinement
If you want to add the sample size (which increases credibility in the title for a small retrospective), you could modify #3 to:
Pediatric MRSA Abscesses: A 3-Year Retrospective Review of 30 Cases with Analysis of Incidence, Antibiotic Susceptibility, and Preventive Strategies
This is longer but follows the format of single-center retrospectives that explicitly state n in the title (as in PMID 35877550: "Renal abscesses in children: an 11-year retrospective study...").
Bottom line: Go with #3 as written, or use the refined version above if your journal allows longer titles. Avoid #5 entirely.
Telme studies related to point 3 topic
Searching PubMed
MRSA pediatric abscess incidence retrospective
Searching PubMed
MRSA children antibiotic susceptibility skin abscess
Searching PubMed
MRSA decolonization prevention recurrence children
Searching PubMed
community-acquired MRSA pediatric skin soft tissue infection treatment
Reading Article
PMID: 35283045
Reading Article
PMID: 31071607
Reading Article
PMID: 35788335
Reading Article
PMID: 39248483
Searching PubMed
CA-MRSA abscess incision drainage antibiotic children trends
Searching PubMed
MRSA abscess incision drainage antibiotic adjunct trimethoprim clindamycin pediatric
Searching PubMed
MRSA prevalence trend children community USA300 epidemiology
Reading Article
PMID: 41132486
Here is a comprehensive, organized summary of all relevant studies for your paper on Topic #3: Pediatric MRSA Abscesses - Incidence, Antibiotic Susceptibility, and Preventive Strategies.
Relevant Studies for Your Paper
The studies are organized under the three pillars of your title.
PILLAR 1 - Incidence / Epidemiology / Trends
1. Rate of MRSA in Pediatric Emergency Departments in Spain
Garriga Ferrer-Bergua L et al. | Anales de Pediatría | 2022 | PMID: 35788335
Design: Retrospective multicenter study, 8 pediatric EDs, 2017-2018
Key findings:
- Overall MRSA rate: 16.6% of all S. aureus isolates
- Highest MRSA rate was in skin abscesses: 29.3% (CI 95%: 21.8-36.8%) - directly relevant to your study
- Risk factors: previous MRSA infection (90% rate), foreign-born children (52%), suppurative skin lesions
- 71.2% were community-related infections
- 41% required admission; no deaths
Relevance to your paper: This is a strong comparable multicenter study. Your single-center data can be positioned relative to this 16.6% baseline. The finding that abscesses have the highest MRSA rate among all SSTIs directly supports your study's focus.
2. Epidemiological Dynamics and Rising Trends of MRSA in Saudi Arabia: A 12-Year Observational Study
Subramanian A et al. | Front Cell Infect Microbiol | 2025 | PMID: 41132486
Design: Retrospective cohort, 4,267 S. aureus isolates over 12 years
Key findings:
- MRSA accounted for 52.7% of all S. aureus isolates
- MRSA prevalence increased significantly over time across all wards (surgical ward OR = 1.115, p < 0.001)
- MRSA more common in blood, skin, and abscess samples
- Rising burden documented with temporal trend analysis
Relevance: Provides a global context for the "rising incidence" narrative of your study and demonstrates the method of temporal trend analysis in a retrospective design.
3. Etiology, Clinical Features, Management, and Outcomes of SSTIs in Hospitalized Children: A 10-Year Review
Yueh CM et al. | J Microbiol Immunol Infect | 2022 | PMID: 35283045
Design: 10-year retrospective review, 1,631 pediatric SSTI patients aged 0-18 years
Key findings:
- Abscess/furuncle/carbuncle = 8.6% of all SSTIs
- Among culture-positive purulent SSTIs: CA-MRSA = 56.8%, CA-MSSA = 22.2%
- MRSA accounted for the majority of culture-proven SSTIs
- Age group 0-1 month and local lymph node reaction were independent predictors for CA-MSSA vs CA-MRSA
Relevance: This is one of the closest comparators to your study - same age group, similar SSTI focus, similar retrospective design. Use for direct comparison in Discussion.
PILLAR 2 - Antibiotic Susceptibility
4. Etiology, Clinical Features, Management, and Outcomes of SSTIs in Hospitalized Children (same as above - dual relevance)
Yueh CM et al. | PMID: 35283045
Susceptibility data:
- MRSA isolates: 100% susceptible to glycopeptides (vancomycin, teicoplanin), linezolid, and daptomycin
- TMP-SMX susceptibility: 98.6% (high - supports its use empirically)
- Clindamycin susceptibility: MRSA 34.2% vs MSSA 78.2% (p < 0.001) - significantly lower in MRSA, an important antibiotic stewardship finding
- Optimal empiric antibiotics depend on age, severity, and local epidemiology
Relevance: Your susceptibility data can be benchmarked against these figures. The clindamycin gap is a major talking point.
5. Penicillin Susceptibility Among S. aureus Skin and Soft Tissue Infections at a Children's Hospital
McNeil JC et al. | Microbiology Spectrum | 2024 | PMID: 39248483
Design: Surveillance study, Texas Children's Hospital, 200 MSSA SSTI isolates (2017-2021), median age 4.2 years
Key findings:
- 9% of MSSA SSTIs were penicillin-susceptible (PSSA)
- PSSA independently associated with hospital admission and need for surgical intervention
- Most PSSA were sequence type 1
- Most clinical labs no longer routinely test penicillin susceptibility - calls for re-evaluation
Relevance: Highlights the nuance of susceptibility testing beyond just MRSA/MSSA dichotomy. Strengthens your argument for comprehensive susceptibility reporting.
6. Efficacy and Safety of Antibiotics in MRSA Infections: A Systematic Review and Network Meta-Analysis
Liu Q et al. | Antibiotics (MDPI) | 2024
Key finding: Linezolid was the most effective antibiotic for both lung infections AND skin/soft tissue infections in MRSA. Consistent with findings from earlier analyses. 20 RCTs included (16 from the US).
Relevance: High-level evidence for antibiotic choice in MRSA SSTIs. Use in your antibiotic management/susceptibility discussion section.
PILLAR 3 - Preventive Strategies / Decolonization
7. Impact of Decolonization Protocols and Recurrence in Pediatric MRSA Skin and Soft-Tissue Infections
Papastefan ST et al. | J Surg Res | 2019 | PMID: 31071607
Design: Single-institution retrospective review, pediatric patients ≤18 yrs, MRSA culture-positive abscesses, 399 patients, I&D performed
Key findings:
- Decolonization protocols were NOT associated with lower recurrence rates
- Recurrence risk factors: previous abscesses, previous MRSA infection, family history of abscess/MRSA, Hispanic ethnicity, fever on admission
- Patients more likely to receive decolonization: prior abscess history, groin/genital abscesses, family members with MRSA, I&D by pediatric surgeon
Relevance: This is the most directly comparable study to yours - same design (retrospective, single institution, pediatric MRSA abscess, I&D). Critically, it challenges decolonization efficacy and reframes prevention toward risk factor modification and family-level interventions. A must-cite.
8. MRSA Eradication and Decolonization in Children Study (Parts 1 & 2)
Moore CM et al. | J Participatory Med | 2020 | PMIDs: 33064109 & 33064098
Design: Patient/parent-centered study on decolonization toolkit development and outcomes
Key findings (Part 1): Development of a community-co-designed MRSA decolonization toolkit
Key findings (Part 2): Patient- and parent-reported outcomes showed decolonization was feasible but adherence was variable; family engagement was identified as key
Relevance: Supports a preventive strategy framework centered on family education and community decolonization protocols - useful for your "Preventive Strategies" section, especially if you found low parental awareness in your cohort.
9. Outpatient Decolonization After Recurrent Skin Infection with PVL-Producing S. aureus
Hanitsch LG et al. | PLoS One | 2020 | PMID: 32315364
Key finding: Treatment repetition is important for successful decolonization - single-course protocols often fail. Outpatient decolonization is feasible and cost-effective when protocols are followed through.
Relevance: Supports recommending repeated or prolonged decolonization courses rather than one-time protocols.
10. Management of Community-Associated Bacterial SSTIs in Children and Prevention of Recurrence
Canadian Paediatric Society (CPS) Position Statement | 2024
CPS guidelines
Key recommendations:
- I&D is the primary treatment for abscess
- Adjunct antibiotics (TMP-SMX or clindamycin) reduce treatment failure and recurrence
- MRSA decolonization with mupirocin nasal ointment + chlorhexidine wash for recurrent cases
- Family and household member decolonization recommended when recurrence occurs
- Reference: Daum RS et al., NEJM 2017 (antibiotics for smaller skin abscesses RCT)
Relevance: A current authoritative guideline - use as the backbone of your Preventive Strategies discussion.
Summary Table for Quick Reference
| # | PMID | First Author | Year | Study Type | Pillar | n | Key Takeaway |
|---|---|---|---|---|---|---|---|
| 1 | 35788335 | Garriga L | 2022 | Retrospective multicenter | Incidence | 403 | MRSA rate 16.6%; highest in abscesses (29.3%) |
| 2 | 41132486 | Subramanian A | 2025 | Retrospective cohort | Incidence | 4,267 | Rising MRSA trend over 12 years |
| 3 | 35283045 | Yueh CM | 2022 | 10-yr retrospective | Incidence + Susceptibility | 1,631 | CA-MRSA = 56.8% of purulent SSTIs; clindamycin resistance high |
| 4 | 39248483 | McNeil JC | 2024 | Surveillance | Susceptibility | 200 | 9% MSSA isolates are penicillin-susceptible; re-examine testing |
| 5 | 31071607 | Papastefan ST | 2019 | Retrospective | Prevention | 399 | Decolonization did NOT reduce recurrence; family factors key |
| 6 | 33064109/98 | Moore CM | 2020 | Patient-centered study | Prevention | - | Family-engaged decolonization toolkit; adherence is key |
| 7 | 32315364 | Hanitsch LG | 2020 | Cohort | Prevention | - | Repeated decolonization courses needed |
Suggested Citation Strategy for Your Introduction
- Open with global/regional MRSA incidence using Subramanian 2025 and Garriga 2022
- Cite Yueh 2022 to show MRSA dominates pediatric SSTIs (>50% of culture-positive cases)
- Segue into antibiotic susceptibility gaps using Yueh 2022 (clindamycin) and McNeil 2024 (penicillin testing)
- Frame prevention discussion using CPS 2024 guideline, Papastefan 2019, and Moore 2020
- Use Papastefan 2019 specifically as your closest design comparator in the Discussion ("Similar to Papastefan et al., our single-center retrospective review of [n] children found...")
This is a shared conversation. Sign in to Orris to start your own chat.